We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIOG icon
3651
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.07B
$144K ﹤0.01%
+1,262
New +$142K
MNDT
3652
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
$144K ﹤0.01%
7,100
FIW icon
3653
First Trust Water ETF
FIW
$1.89B
$143K ﹤0.01%
+1,711
New +$140K
MEC icon
3654
Mayville Engineering Co
MEC
$677M
$143K ﹤0.01%
7,083
-5,016
-41% -$88.5K
QNCX icon
3655
Quince Therapeutics
QNCX
$24.4M
$143K ﹤0.01%
14
-53
-79% -$444K
CLFD icon
3656
Clearfield
CLFD
$436M
$142K ﹤0.01%
3,798
-6,628
-64% -$235K
FRAF icon
3657
Franklin Financial Services
FRAF
$283M
$142K ﹤0.01%
4,462
-1,923
-30% -$58.4K
IJH icon
3658
iShares Core S&P Mid-Cap ETF
IJH
$124B
$142K ﹤0.01%
2,650
-24,045
-90% -$1.3M
RSPD icon
3659
Invesco S&P 500 Equal Weight Consumer Discretionary ETF
RSPD
$330M
$142K ﹤0.01%
+2,871
New +$140K
XHE icon
3660
State Street SPDR S&P Health Care Equipment ETF
XHE
$163M
$142K ﹤0.01%
+1,097
New +$135K
GHL
3661
DELISTED
Greenhill & Co., Inc.
GHL
$142K ﹤0.01%
9,060
-10,219
-53% -$170K
KF
3662
Korea Fund
KF
$236M
$141K ﹤0.01%
+2,600
New +$117K
UPRO icon
3663
ProShares UltraPro S&P 500
UPRO
$5.38B
$141K ﹤0.01%
2,486
-6,562
-73% -$344K
BCYC
3664
Bicycle Therapeutics
BCYC
$270M
$140K ﹤0.01%
4,600
-15,900
-78% -$480K
CROX icon
3665
PUT
Crocs
CROX
$6.47B
$140K ﹤0.01%
1,200
LD
3666
DELISTED
iPath Bloomberg Lead Subindex Total Return ETN due June 24, 2038
LD
$140K ﹤0.01%
3,000
FXR icon
3667
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$753M
$139K ﹤0.01%
2,355
+407
+21% +$24.1K
VUG icon
3668
Vanguard Morningstar Growth ETF
VUG
$225B
$139K ﹤0.01%
+2,916
New +$132K
CMRE icon
3669
Costamare
CMRE
$1.87B
$138K ﹤0.01%
11,680
-41,821
-78% -$450K
TNA icon
3670
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.38B
$138K ﹤0.01%
1,411
+752
+114% +$70.1K
BELFB
3671
Bel Fuse Inc Class B
BELFB
$3.91B
$137K ﹤0.01%
9,427
-3,162
-25% -$52K
BLFS icon
3672
BioLife Solutions
BLFS
$1.57B
$137K ﹤0.01%
3,089
-14,431
-82% -$508K
OVID icon
3673
Ovid Therapeutics
OVID
$435M
$137K ﹤0.01%
35,227
-4,850
-12% -$19.1K
PAVM icon
3674
PAVmed
PAVM
$39.4M
$137K ﹤0.01%
47
-69
-59% -$163K
TYME
3675
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$137K ﹤0.01%
108,973
+17,331
+19% +$25K

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.